In contrast to the domination of immature T-cells and B10 in B1 and B2 tumor subtypes, in more aggressive TETs, the immune infiltrate is composed mainly of fully differentiated CD4 and CD8 single-positive T-lymphocytes, which represent the main cellular components of anti-tumor immune reactions. Here, CD4 is linked to neoplasm.